- Home
- IMRX vs NMS Comparison
IMRX vs NMS Comparison
Compare IMRX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- NMS
- Stock Information
- Founded
- IMRX 2008
- NMS 1993
- Country
- IMRX United States
- NMS United States
- Employees
- IMRX N/A
- NMS N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- IMRX Health Care
- NMS Finance
- Exchange
- IMRX Nasdaq
- NMS Nasdaq
- Market Cap
- IMRX 62.7M
- NMS 71.0M
- IPO Year
- IMRX 2021
- NMS N/A
- Fundamental
- Price
- IMRX $2.02
- NMS $12.23
- Analyst Decision
- IMRX Buy
- NMS
- Analyst Count
- IMRX 7
- NMS 0
- Target Price
- IMRX $12.80
- NMS N/A
- AVG Volume (30 Days)
- IMRX 4.9M
- NMS 12.0K
- Earning Date
- IMRX 02-28-2025
- NMS 01-01-0001
- Dividend Yield
- IMRX N/A
- NMS 4.11%
- EPS Growth
- IMRX N/A
- NMS N/A
- EPS
- IMRX N/A
- NMS N/A
- Revenue
- IMRX N/A
- NMS N/A
- Revenue This Year
- IMRX N/A
- NMS N/A
- Revenue Next Year
- IMRX N/A
- NMS N/A
- P/E Ratio
- IMRX N/A
- NMS N/A
- Revenue Growth
- IMRX N/A
- NMS N/A
- 52 Week Low
- IMRX $1.00
- NMS $9.21
- 52 Week High
- IMRX $7.68
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- IMRX 47.82
- NMS 33.93
- Support Level
- IMRX $1.84
- NMS $12.20
- Resistance Level
- IMRX $3.80
- NMS $12.30
- Average True Range (ATR)
- IMRX 0.29
- NMS 0.14
- MACD
- IMRX -0.03
- NMS 0.01
- Stochastic Oscillator
- IMRX 9.18
- NMS 27.25
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.